{"name":"Cumberland Pharmaceuticals","slug":"cumberland-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":42010949,"revenueGrowth":360.5,"grossMargin":0,"rdSpend":5566498,"netIncome":-2836128,"cash":76823992,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Caldolor","genericName":"Caldolor","slug":"caldolor","indication":"Other","status":"marketed"},{"name":"liquid lactulose","genericName":"liquid lactulose","slug":"liquid-lactulose","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Caldolor","genericName":"Caldolor","slug":"caldolor","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"liquid lactulose","genericName":"liquid lactulose","slug":"liquid-lactulose","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQbkk4RVM2cUo5VGtyaWdnc3RMSG53bUlMbEtNb2dyZHcwWEd1M3BJaGIzclhvTzFhLUJXQlJlRXpLLS15bWN5MkRWMXE4YzNxX00tZEk5ZGp2ZWtkdUduUHV0eE9wY0p0Sm5DYzZNTHd4QjdWdS1lTU5UMVo3U0tKUEl4eE5DcmhkbXhXbGRMbmxXOFN0aVJXUl9wVlRwdTJfTnMzU1hoT0VBTG4xeFA3WW1UOFJNTEJ1VEpJMmFPNlN6SDBFWXJ0bGQwN0lRaDYxX2tQZl9XOXJ6ZGp4U3Vpby1mUDhmMzFrbVMwU01ycnlWZEh3NkVMSTN6SkEyc2lzRnpKeUVFSDRRc3N1WjV1WWxKOERXSkI1cmxjVmh0VndTWjRuTmNqM095cW1Jc2pVcUFRRkU4TGFjOXN3UlBianctbUxfb1NhMWF5Z1BR?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - B","headline":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOSTZrRDc2MU5vaGlaQURCdTJGZXN1NXdKWGhGVlUyMEkyUUx0MjBOS2JxZVByM0tyZFkxc1k1Z2YtUXBTVkxVV29HY3Y0VHNvR0o3S1kwcFVISEZXX21HUGgtZzNrNmNWYXJiM0o3WFpZLWUyU0VEakNtX3JXREV5SzNNaTNsOTk2bW9LcWdzbWVvY3RGaXk3NVROZTctVnlFQXZWQUlLTVJBTGpwSzZ4NGVaTjEyNXpmTllkZQ?oc=5","date":"2026-03-17","type":"pipeline","source":"Stock Titan","summary":"New site spotlights chemo nausea patch that helps for five days - Stock Titan","headline":"New site spotlights chemo nausea patch that helps for five days","sentiment":"neutral"},{"date":"2026-03-09","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPbmdWMzdRc3JIV1VrMEw1Z1YyTWtKXzhpWkp2VXFteV9vWWxqYjBRam9kcW11WkJpVnhwUkxWc1BJNDkteUZiSm5CVUt3N3UwMWNfaDhZTjQ0MXg5dWk2cUJxSEJ2cWI3ODRYQTlWb0lVekdQOUhMRUxoRlZManZtZWNRemxGbnFfMEdqYkQ5V3VfZlpkb0xlZnBURU1FcFBuVm9HNUNNVmhDUTZ1RTZRaDlyUElDbzdLckNkSA?oc=5","date":"2026-03-03","type":"earnings","source":"Stock Titan","summary":"Cumberland revenue climbs 18% as Talicia, Vibativ and Caldolor expand access - Stock Titan","headline":"Cumberland revenue climbs 18% as Talicia, Vibativ and Caldolor expand access","sentiment":"neutral"},{"date":"2026-03-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOVWplNjJuWGJoQ094RFJiX1VneFFaRU1LUnl0VDJhOGJDV0dRLXVJOXFWSm1QNFpRWkU5ZUZNQzE0LWoyQTliU2lHQm9IMGJUa0swbURRdWRJZDZyelA5eVRpbEN5aUxiZkpOU2NKVXp6ajdkSHgwSnhaSm5FTGtId2Z2UUlvMGF4R25tQnZfbGtnbWxBQmNCekVvWE9YWVlPRnZSSmZxZVBpN0k?oc=5","date":"2026-02-25","type":"pipeline","source":"Stock Titan","summary":"All-in-one H. pylori pill Talicia gets major U.S. sales push - Stock Titan","headline":"All-in-one H. pylori pill Talicia gets major U.S. sales push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQM3JXS2xFUV9DRVRCdmFFODhLYUNDRGtKTHdqSkc0ejQxQlB6YkVYUy1pTWRwb1RqbTltekZOQnkzN2g1UG9Cal81X1RiVnBUbVB0N1ExUC1TbzlqeGVsNjVkVUcxb2JKeHdpU052bG1lRDhsMnBJLUZuTDhReTJnekVZc0t2MWQxdFQ0Q2xZaG5CbEZvR2ptbS00VExQUXhLUmRsdWhYTjFsLThtbE9vQnBaMTUxbnk2Y05CaFRWYTQ?oc=5","date":"2026-02-24","type":"pipeline","source":"Stock Titan","summary":"Cumberland Pharma schedules Mar. 3 call on 2025 results and company update - Stock Titan","headline":"Cumberland Pharma schedules Mar. 3 call on 2025 results and company update","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"earnings","source":"simplywall.st","summary":"Little Excitement Around Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Revenues As Shares Take 31% Pounding - simplywall.st","headline":"Little Excitement Around Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Revenues As Shares Take 31% Pounding","sentiment":"neutral"},{"date":"2026-02-04","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNeWg2Ql81aGxqWVVJZHEwSC1rUXdETmNVaUZET0FiSFdNU1NoVWtIaE5LLWpmOEVZcnJyeFVIMVRBaERkZHFwa1VSdVZZSEVkeWx0T3diQ3p3UGR0RlFkYklwdkF6aUVZWWRFRHdqOVpLSUZUTmpzU2hIYkstMi1naVBuR2lXcjRwLWZXVWNBVDNQUlUt?oc=5","date":"2025-12-16","type":"pipeline","source":"Yahoo Finance","summary":"Cumberland Pharmaceuticals Leads 3 Promising Penny Stocks - Yahoo Finance","headline":"Cumberland Pharmaceuticals Leads 3 Promising Penny Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPYUp6OHZyaWxhQjB2UGhPdlptZjU1aUJFUVJiYTRyN0lMOE1uSk1ZWnBKcWsyR2FGLUx2MkRTTVBPNjlEMVVxdzRMbUp5ME96YkE0OWpwQ080LTRBd0NuSG5hNTR4VTZ3d1labE0yYVZlMTM3QlBuc0k0Wl9YeWNsTUYzZXQwbjgzSE56SWczbGV4dlB0ZzVJelNfVEZXZw?oc=5","date":"2025-11-05","type":"earnings","source":"Mexico Business News","summary":"Cumberland Pharmaceuticals Reports 12% Revenue Growth in 2025 - Mexico Business News","headline":"Cumberland Pharmaceuticals Reports 12% Revenue Growth in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNWXFBd1BpbjB6MUN5eTFIaXhsR1B6eGI1T0tqSXJDa0k4ajNHYVdCNnU4c3VIb204TnlqQnBHTDQ4X1lLTE5KeWhWYWVxRUJuY0NtVG1aS00tcEJBWnJFUmZYM1NONHlHQjFMbEYxNTZIWjVuNzctNG1ua0tXWVpXQndYMEE1UTN3eUw4R3ZBcW1nR2hIVFRCaWc1cmw5Zi1JYVg2cHQtdGdPQ2lPMzY4WEM3WGVPTFJfX1R2MXpR?oc=5","date":"2025-11-04","type":"earnings","source":"PR Newswire","summary":"CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH - PR Newswire","headline":"CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOODZsSTBYSkRSR0dHV1I3eURmaDRsSHo5NTEyRmw5WUhtZ09ZOEdXbjY3VF9LRjRnNTNhZy16am1ndDhzYlVQOE1rS0l6QzdSSUlPYnMwTzJhVXZZTGpNbWpyMEFNTkZfQzBKSGtmdHlHQUYtYzB0anBkZkFkMXJrNGtTME4xOFQ2VnFxUjRwZEFESHI1cEZrTS01WnZLb1VwdnlkMFdGcHFXMzF6bWM5TDh2MjVXNlhQaGxfbTFjQ2FVeDNOQzJLNTJJVWxoRXVPeUpZMlhuSUxRbEVLdzk0b09JVDMtcVFxRDJWdmRSckNhX3NnaGs2d2E5R0pOMm9G?oc=5","date":"2025-10-20","type":"regulatory","source":"PR Newswire","summary":"CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO - PR Newswire","headline":"CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcnZIQm4teTBLMktCRnVteS1MdUI0b3dWWFBzMlZxcWo0eW9VejRYcktodHlONjNfdUFGb1piMlp4cS1HNmlMdDZxU0p6Uk1ReUZxWWlkYWtnV2RMZkYtSmd0QzQ5Z2c0SUJYUXIzOU96OXVpQW1RZWVmWC1NeXB0VDZGZmNUeTJheTZERkMtVHhPQWVuS0VIOHdndG5xbFBnR29rSEZOLTk1OWkzTG5pVHVNZTQ2NF9RRldjRjRZdWFfM25GNUFWQUlFOFBzM0JmSzNHOTJIX2lMLTZHZEhhei1lWkx6WTA?oc=5","date":"2025-10-13","type":"pipeline","source":"PR Newswire","summary":"CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. - PR Newswire","headline":"CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOdWhnS1hSVFpjNEV1OTZJTU04OTQzeC11Q1dLeWNseTRwX2VVN0xkTEFzQkp5YXNOeXVfU2pvUkszaUhYcDRpT0U3anFQSm5nQ0M2VEdBR2E3Y01SbEZmQXh1ckNmMGZRanlpcmk2NUt5X3psRHU5MU5HTE5CbXR0cDc4NGZSWngtWFJiMEh0VWdfNTQxa1YwWWFYN1h1M2ZPVjlFNFBzWQ?oc=5","date":"2025-05-22","type":"pipeline","source":"The Business Journals","summary":"Q&A: Cumberland Pharmaceuticals CEO A.J. Kazimi weighs in on industry challenges, strengths - The Business Journals","headline":"Q&A: Cumberland Pharmaceuticals CEO A.J. Kazimi weighs in on industry challenges, strengths","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":42010949,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":42010949,"period":"2022-12-31"},{"value":9123680,"period":"2022-12-31"},{"value":11413072,"period":"2022-09-30"},{"value":10299152,"period":"2022-06-30"},{"value":11175045,"period":"2022-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":5566498,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-2836128,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":76823992,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}